Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2 Mercaptopropionylglycine
2. 2 Thiol Propionamido Acetic Acid
3. 2 Thiolpropionamidoacetic Acid
4. 2-mercaptopropionylglycine
5. 2-thiol-propionamido-acetic Acid
6. 2-thiolpropionamidoacetic Acid
7. Acadione
8. Acid, 2-thiol-propionamido-acetic
9. Acid, 2-thiolpropionamidoacetic
10. Alpha Mercaptopropionylglycine
11. Alpha-mercaptopropionylglycine
12. Captimer
13. Meprin
14. Mercaptopropionylglycine
15. Thiola
16. Thiopronine
17. Tiopronine
1. 1953-02-2
2. N-(2-mercaptopropionyl)glycine
3. Acadione
4. Captimer
5. Thiopronine
6. Mucolysin
7. Capen
8. Thiola
9. Tiopronine
10. Epatiol
11. 2-(2-sulfanylpropanoylamino)acetic Acid
12. Thiosol
13. Glycine, N-(2-mercapto-1-oxopropyl)-
14. Tiopronin (thiola)
15. A-mercaptopropionyl Glycine
16. 2-(2-mercaptopropanamido)acetic Acid
17. Nsc-760416
18. Chembl1314
19. C5w04go61s
20. N-(2-mercaptopropanoyl)glycine
21. Thiopronin
22. Chebi:32229
23. 2-(2-sulfanylpropanamido)acetic Acid
24. Ncgc00159422-02
25. Ncgc00159422-04
26. Sutilan
27. Dsstox_cid_3678
28. Glycine, N-(2-mercapto-1-oxopropyl)- (9ci)
29. Dsstox_rid_77142
30. Dsstox_gsid_23678
31. Thiolpropionamidoacetic Acid
32. Tioglis
33. Vincol
34. Cas-1953-02-2
35. Meprin (detoxicant)
36. N-(2-mercapto-1-oxopropyl)glycine
37. Tiopronine [inn-french]
38. Tioproninum [inn-latin]
39. Tiopronino [inn-spanish]
40. (2-mercaptopropionyl)glycine
41. Tiopronin [inn:dcf:jan]
42. Tiopronino
43. Tioproninum
44. Ccris 1935
45. (s)-2-(2-mercaptopropanamido)acetic Acid
46. Einecs 217-778-4
47. Thiola (tn)
48. Brn 1859822
49. Thiola Ec
50. Tiopronin (jan/inn)
51. Tiopronin [inn]
52. Tiopronin [jan]
53. Tiopronin [mi]
54. Glycine, N-(2-mercaptopropionyl)-
55. Tiopronin [vandf]
56. 2-mercapto-propionylglycine
57. Tiopronin [mart.]
58. Tiopronin [who-dd]
59. (2-mercaptopropanoyl)glycine
60. Unii-c5w04go61s
61. Schembl19989
62. Mls006010632
63. Alpha-mercaptopropionyl Glycine
64. Mercaptopropionylglycine-
65. N-(2-sulfanylpropanoyl)glycine
66. Tiopronin [orange Book]
67. Dtxsid4023678
68. N-(2-mercaptopropionyl) Glycine
69. N-(2-mercaptopropanoyl) Glycine
70. Acadione; Capen; Epatiol; Vincol
71. Hms3264b11
72. Hms3655l15
73. Pharmakon1600-01506190
74. Amy39003
75. Bcp13354
76. Hy-b0373
77. 2-(2-mercaptopropanamido)aceticacid
78. Tox21_111654
79. Bdbm50020805
80. Mfcd00004861
81. Mfcd30157366
82. Nsc760416
83. S2062
84. (2-mercaptopropionylamino)acetic Acid
85. Akos015895408
86. N-(2-mercaptopropionyl)glycine, 99%
87. Tox21_111654_1
88. Ac-2087
89. Ccg-214007
90. Db06823
91. Nsc 760416
92. (2-mercapto-propionylamino)-acetic Acid
93. Ncgc00159422-03
94. As-12522
95. Smr001550282
96. Sy262996
97. Ft-0603530
98. Ft-0653686
99. Sw219206-1
100. T2614
101. Tiopronin, Vetranal(tm), Analytical Standard
102. C73708
103. D01430
104. Ab00376096_02
105. 953t022
106. A813794
107. Q414456
108. Sr-01000942263
109. J-012651
110. Sr-01000942263-1
111. Tiopronin, Dextiopronin, Tiopronin (n-2-mercaptopropionyl Glycine)
Molecular Weight | 163.20 g/mol |
---|---|
Molecular Formula | C5H9NO3S |
XLogP3 | -0.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 163.03031432 g/mol |
Monoisotopic Mass | 163.03031432 g/mol |
Topological Polar Surface Area | 67.4 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 148 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Tiopronin is indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria consisting of a urinary cystine concentration greater than 500 mg/day, and who have failed treatment with non-pharmacological measures of increased fluid intake, decreased sodium and protein intake, and urine alkalinization.
G - Genito urinary system and sex hormones
G04 - Urologicals
G04B - Urologicals
G04BX - Other urologicals
G04BX16 - Tiopronin
Absorption
Tiopronin undergoes slow absorption, reaching peak plasma concentration 3-6 hours after ingestion. In a study of healthy subjects, the bioavailability of total and unbound tiopronin was found to be 63% and 40%, respectively.
Route of Elimination
Tiopronin is 100% excreted in urine.
Volume of Distribution
The volume of distribution of tiopronin is high at 455 L, indicating that a large portion of the drug is bound to tissues outside plasma.
Clearance
Total renal clearance for the total and unbound fractions of tiopronin were found to be 3.3 and 13.3 L/h respectively.
The principle metabolite of tiopronin is 2-mercaptopropionic acid (2-MPA). Between 10-15% of the drug is metabolized to 2-MPA via hydrolysis.
Tiopronin has a long terminal half life of 53 hours in healthy subjects. However, the unbound drug fraction of tiopronin is eliminated much more rapidly from plasma with a calculated half life of 1.8 hours.
Kidney stones form when the solubility limit is exceeded and urine becomes supersaturated with endogenous cystine. Tiopronin is an active reducing agent which undergoes a thiol-disulfide exchange with cystine to form a water-soluble mixed disulfide complex. Thus, the amount of sparingly soluble cystine is reduced. By reducing urinary cystine concentrations below the solubility limit, tiopronin helps reduce cystine stone formation.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?